Definitive Contract HHSN268201700005C
Award Date
11/7/16
Potential Completion Date
11/1/20
Potential Value
$1.8M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
State Of California Controllers Office
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
San Francisco, CA 94103, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of HHSN268201400005C, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Regents of the University of California, San Francisco (UCSF). The contract is for the "VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES" program, with a base period from November 15, 2013 to November 14, 2014 and a total completion date of November 14, 2016. The contract, which is...
This is a $1,379,807.12 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF). The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. UCSF is a leading academic medical center and research institution that receives substantial federal funding for biomedical research, healthcare services,...
This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on June 15, 2010. The contract, valued at $2,025,201.08, supports research on hip morphology and limb-specific risk factors for radiographic hip osteoarthritis. UCSF, a leading academic medical center and research institution, is the prime contractor for this effort....
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on February 2, 2009. The $3,319,012.92 Definitive Contract is for biomedical research and has a period of performance through July 31, 2016. The contract does not have a set-aside designation. As a leading academic medical center and research institution, UCSF has a strong...
This $639,119.55 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to The Regents of the University of California, San Francisco (UCSF), a state-controlled institution of higher learning, for the DBDR REDS-III Domestic Site Phase 3 project. The contract is a delivery order under the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites major program, with a period of...
This is a $6,734,645.00 cost-reimbursement task order contract awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to the Regents of the University of California, San Francisco (UCSF). The contract is for the "SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - TASK AREA A - YEAR 1" project, which is not set aside for any specific category. The contract has a completion date of June 17, 2025. UCSF is a prominent academic...
The federal contract award was issued by the National Heart, Lung, and Blood Institute, a civilian agency, to the Regents of the University of California for biomedical (applied/exploratory) research. The award has a ceiling value of $1,134,369.00 and was issued on April 15, 2003 as a definitive cost-no-fee contract. The period of performance extends through September 29, 2011. This contract award is not associated with a set-aside and does not appear to be part of a larger contract vehicle...
This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) on March 29, 2010. The contract, valued at $1,930,904.73, is for a recovery act project to provide radiologic outcomes for the Osteoarthritis Initiative (OAI), which is sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract is a firm fixed price arrangement and...
This is a $48,051,765.59 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA) to provide biomedical research and related services. The contract has no set-aside designation and was awarded on September 22, 1994 with a completion date of June 20, 2014. As the prime contractor, UCLA's Office of Research Administration is leveraging the university's...
The Department of Health and Human Services National Institutes of Health awarded a definitive, cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for $6,657,300.68. The contract is for biomedical (basic) services and does not have a set-aside designation. UCSF, a public academic medical center and research university, is providing services through its Controller's Office division. The contract commenced on September 30, 2004 and is scheduled for completion...